Tetsuro Ito News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Esketamine has showcased promising results in a major clinical trial, proving more effective than standard treatments for treatment-resistant depression. Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Cham ....

Allanh Young , Jozefien Buyze , Richard Frey , Pierre Michel Llorca , Albinoj Oliveira Maia , Andreas Reif , Kerstin Cebulla , Thomas Messer , Yordan Godinov , Yerkebulan Kambarov , Tetsuro Ito , Dong Jing Fu , Albino Oliveira Maia , Champalimaud Foundation Neuropsychiatry Unit , Drug Administration , National Institute Of Mental Health , European Medicines Agency , Esketamine Nasal Spray , Esketamine Nasal , Janssen Pharmaceutica , Champalimaud Foundation , Neuropsychiatry Unit , National Institute , Mental Health , Potential Solution , Head Comparison ,